1. Home
  2. PCRX vs ANDE Comparison

PCRX vs ANDE Comparison

Compare PCRX & ANDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • ANDE
  • Stock Information
  • Founded
  • PCRX 2006
  • ANDE 1947
  • Country
  • PCRX United States
  • ANDE United States
  • Employees
  • PCRX N/A
  • ANDE N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • ANDE Farming/Seeds/Milling
  • Sector
  • PCRX Health Care
  • ANDE Industrials
  • Exchange
  • PCRX Nasdaq
  • ANDE Nasdaq
  • Market Cap
  • PCRX 1.2B
  • ANDE 1.3B
  • IPO Year
  • PCRX 2011
  • ANDE N/A
  • Fundamental
  • Price
  • PCRX $26.67
  • ANDE $40.90
  • Analyst Decision
  • PCRX Buy
  • ANDE Buy
  • Analyst Count
  • PCRX 6
  • ANDE 3
  • Target Price
  • PCRX $30.00
  • ANDE $51.67
  • AVG Volume (30 Days)
  • PCRX 766.6K
  • ANDE 308.8K
  • Earning Date
  • PCRX 08-05-2025
  • ANDE 08-04-2025
  • Dividend Yield
  • PCRX N/A
  • ANDE 1.91%
  • EPS Growth
  • PCRX N/A
  • ANDE N/A
  • EPS
  • PCRX N/A
  • ANDE 2.35
  • Revenue
  • PCRX $705,848,000.00
  • ANDE $11,539,093,000.00
  • Revenue This Year
  • PCRX $7.36
  • ANDE $9.10
  • Revenue Next Year
  • PCRX $10.07
  • ANDE $2.78
  • P/E Ratio
  • PCRX N/A
  • ANDE $17.37
  • Revenue Growth
  • PCRX 2.25
  • ANDE N/A
  • 52 Week Low
  • PCRX $12.61
  • ANDE $31.03
  • 52 Week High
  • PCRX $27.64
  • ANDE $51.58
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 67.86
  • ANDE 64.89
  • Support Level
  • PCRX $25.14
  • ANDE $39.92
  • Resistance Level
  • PCRX $27.04
  • ANDE $41.71
  • Average True Range (ATR)
  • PCRX 0.78
  • ANDE 1.16
  • MACD
  • PCRX 0.18
  • ANDE 0.23
  • Stochastic Oscillator
  • PCRX 88.79
  • ANDE 78.68

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About ANDE Andersons Inc. (The)

Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.

Share on Social Networks: